About
Research & Development
Neurodegenerative Diseases
News & Publications
Contact
Who we are
About
PharmatrophiX
About
Our mission, story, and approach.
Leadership
Team, board, and scientific advisors
Peer Reviewed Funding & Investors
Our science
Research &
Development
Research & Development
Our science and development philosophy.
Pipeline
Programs and indications across our development stages.
·
May 4, 2026
·
read
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial
Share
Peer-reviewed
All stories →
Stay informed
New data, new trials, occasional essays. No more than monthly.
Leave this field empty if you're human:
Unsubscribe anytime. We never share your email.
